SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Conexeu Sciences Inc. (NASDAQ:CNXU)

US · Delayed Price · Currency is USD
3.66+0.54 (+17.31%)
 
Market Cap97.94M-72.0%
Revenue (ttm)n/a
Net Incomen/a
EPSn/a
Shares Out26.76M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume327,847
Open3.20
Previous Close3.12
Day's Range3.15 - 3.74
52-Week Range3.05 - 18.79
Beta0.51
Analystsn/a
Price Target20.00(+446.45%)
Earnings Daten/a
Insider Score
––Not scored
CNXU Insider Score

Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

About CNXU

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.

Address
50 W Liberty St, Suite 880, Reno, NV, 89501, US
Market Cap
98 million
Employees
4
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$838.00K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
+17.31%
5 Days
+4.27%
1 Month
-26.36%
6 Months
-72.00%
1 Year
-72.00%

$CNXU stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CNXU holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CNXU's directors and management

Net Shares Purchased by Insiders−2M−1M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CNXU Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New CNXU patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CNXU from public contracts

Source: USAspending.gov

CNXU Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for CNXU yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from CNXU’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
3
Sells
0
Buy Value
$838.00K
Distinct Buyers
2

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Company Directory & Stock Ticker Database | InsiderBuying.com